Jubilee Brown, MD

Articles

Dr. Brown on the Promise of the ROCSAN Trial in Gynecologic Carcinosarcomas

November 2nd 2021

Jubilee Brown, MD, discusses the promise of the phase 2/3 ROCSAN trial in recurrent gynecologic carcinosarcomas.

Dr. Brown on the Utility of PARP Inhibitors in Recurrent Platinum-Sensitive Ovarian Cancer

October 27th 2021

Jubilee Brown, MD, discusses the utility of PARP inhibitors in patients with recurrent platinum-sensitive ovarian cancer.

Dr. Brown on the Clinical Implications of the PRIMA Trial in Ovarian Cancer

October 5th 2021

Jubilee Brown, MD, discusses the clinical implications of the phase 3 PRIMA trial in advanced ovarian cancer.

Dr. Brown on Future Directions for Surgery in Ovarian Cancer

February 5th 2021

Jubilee Brown, MD, discusses future directions for surgery in ovarian cancer.

Dr. Brown on the Utility of Minimally Invasive Surgery in Ovarian Cancer

January 8th 2021

Jubilee Brown, MD, discusses the utility of minimally invasive surgery in ovarian cancer.

Dr. Brown on Germline and Somatic Testing in Ovarian Cancer

April 2nd 2020

Jubilee Brown, MD, discusses germline and somatic testing in ovarian cancer.

Dr. Brown on the Importance of Genetic Testing in Ovarian Cancer

August 30th 2018

Jubilee Brown, MD, professor of gynecologic oncology, Levine Cancer Institute, Carolinas HealthCare System, discusses the importance of genetic testing in patients with ovarian cancer.

Dr. Brown on the Adoption of Genetic Testing

August 22nd 2018

Jubilee Brown, MD, professor of gynecologic oncology, Levine Cancer Institute, Carolinas HealthCare System, discusses the adoption of genetic testing into routine clinical practice.

Dr. Brown on Genetic Counseling for Breast and Ovarian Cancer

March 14th 2017

Jubilee Brown, MD, obstetrician-gynecologist, Levine Cancer Institute, Carolinas HealthCare System, discusses genetic counseling for patients with breast and ovarian cancer.